Korea may speed development of new drugs

Local drugmakers should focus on lead compounds that have been discontinued in early clinical stage, to elevate the success rate of new drugs’ development, said a local professor.

In a scientific seminar, Professor Kim Hyung-choon of Kangwon University said that Korea’s pharmaceutical firms should screen such drug instead of developing new chemical entities, citing a novel anti- Parkinson’s ...